Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of prostate cancer

The prognosis depends on whether the prostate cancer is localized, regional, or metastatic at the time of diagnosis. Because there is screening for prostate cancer, most of the time it is caught before it spreads to other parts of the body. 79.2% are diagnosed at the local stage and the 5-year survival for localized prostate cancer is 100.0%.

In general prostate cancer has excellent survival rates, but death rates are higher in African American men, men who have advanced stage cancer, and men who are between the ages of 75 and 84. The overall 5-year survival rate for prostate cancer patients during the period 2007-2013 was 98.6%.

Prostate cancer is the second leading cause of cancer death in men. Death rates have been falling on average 3.4% each year over 2005-2014. In 2014, there were an estimated 3,085,209 men living with prostate cancer in the United States and in 2017 there are an estimated  26,730 men will die of this disease (6).


Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2017